Early surgical debridement in the management of infectious scleritis after pterygium excision.

Journal of Ophthalmic Inflammation and Infection
Ethan H TittlerSamuel C Yiu

Abstract

The purpose of this study was to report outcomes of infectious scleritis after pterygium surgery, managed with antibiotic therapies and early scleral debridement. Retrospective chart review of 13 consecutive cases of infectious scleritis after pterygium excision between 1999 and 2009 was conducted. Collected data included prior medical and surgical history, latency period between pterygium surgery and presentation of infectious scleritis, culture and histopathologic findings, antibiotic regimen, length of hospital stay, visual acuity before and after treatment, and complications. Median follow-up was at 14 months. Twelve patients underwent prompt surgical debridement after infectious scleritis diagnosis (median, 2.5 days). Debridement was delayed in one patient. Median hospital stay was 3 days. Best-corrected visual acuity improved in ten patients, remained stable in one patient, and decreased in two patients following treatment. Complications included scleral thinning requiring scleral patch graft (1/13), glaucoma (3/13), and progression to phthisis bulbi (1/13). No patients required enucleation. In contrast to the generally poor outcomes in the literature, early surgical debridement of pterygium-associated infectious scleriti...Continue Reading

References

Nov 15, 1991·American Journal of Ophthalmology·M G Reynolds, E Alfonso
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·J C NickelJ W Costerton
Jun 1, 1981·American Journal of Ophthalmology·F CodèreW B Jackson
Feb 15, 1993·American Journal of Ophthalmology·S L Maskin
Jan 1, 1995·Annual Review of Microbiology·J W CostertonH M Lappin-Scott
Mar 20, 1998·The British Journal of Ophthalmology·C P LinM C Tsai
Apr 16, 1998·The British Journal of Ophthalmology·C H HsiaoR J Tsai
May 21, 1999·Science·J W CostertonE P Greenberg
Jul 16, 1999·Ophthalmology·W P RionoN A Rao
Jan 13, 2000·Cornea·F C HuangS H Tseng
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·A BroounK Lewis
Oct 12, 2000·American Journal of Ophthalmology·D A JabsM J Marsh
Oct 26, 2001·Nature·M WhiteleyE P Greenberg
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Giorgia BorrielloPhilip S Stewart
Oct 7, 2004·Applied and Environmental Microbiology·Erin WernerPhilip S Stewart
Jan 26, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S DuaR M Aris

❮ Previous
Next ❯

Citations

Nov 12, 2013·Indian Journal of Ophthalmology·Zia Sultan Pradhan, Pushpa Jacob
Jul 28, 2012·Middle East African Journal of Ophthalmology·Pho Nguyen, Samuel C Yiu
Dec 3, 2014·Colloids and Surfaces. B, Biointerfaces·Vinay K SinghKunal Pal
Feb 16, 2013·Survey of Ophthalmology·Rishi R DoshiEmmett T Cunningham
Feb 22, 2013·Expert Opinion on Pharmacotherapy·Robert M BeardsleyPhoebe Lin
Oct 31, 2016·Survey of Ophthalmology·J Daniel DiazDavid C Gritz
Oct 19, 2017·Ocular Immunology and Inflammation·Sumayya AhmadGuillermo Amescua
May 2, 2018·JAMA Ophthalmology·Kareem MoussaJulie M Schallhorn
Jul 22, 2020·American Journal of Audiology·Laura CocoNicole Marrone
Jul 7, 2018·Open Forum Infectious Diseases·Richelle L Guerrero-Wooley, James E Peacock
Feb 9, 2021·American Journal of Ophthalmology Case Reports·Zeba A Syed, Christopher J Rapuano
Apr 27, 2020·Taiwan Journal of Ophthalmology·Luz Elena Concha Del RíoLourdes Arellanes-Garcia
Jul 6, 2021·Eye & Contact Lens·Julia YuChristopher J Rapuano

❮ Previous
Next ❯

Methods Mentioned

BETA
scrapings
lavage

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.